<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd"><id>2957048</id><setSpec>journal_article</setSpec><setSpec>doc-type:article</setSpec><setSpec>ddc:610</setSpec><setSpec>journal_articleFtxt</setSpec><setSpec>open_access</setSpec>

<genre>article</genre>

<titleInfo><title>Lack of consideration of sex and gender in COVID-19 clinical studies</title></titleInfo>


<note type="publicationStatus">published</note>


<note type="qualityControlled">yes</note>

<name type="personal">
  <namePart type="given">Emer</namePart>
  <namePart type="family">Brady</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Mathias Wullum</namePart>
  <namePart type="family">Nielsen</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Jens Peter</namePart>
  <namePart type="family">Andersen</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Sabine</namePart>
  <namePart type="family">Oertelt-Prigione</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">287243520</identifier><description xsi:type="identifierDefinition" type="orcid">0000-0003-3856-3864</description></name>







<name type="corporate">
  <namePart/>
  <identifier type="local">287236199</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>








<abstract lang="eng">Sex and gender differences impact the incidence of SARS-CoV-2 infection and COVID-19 mortality. Furthermore, sex differences influence the frequency and severity of pharmacological side effects. A large number of clinical trials to develop new therapeutic approaches and vaccines for COVID-19 are ongoing. We investigated the inclusion of sex and/or gender in COVID-19 studies on ClinicalTrials.gov, collecting data for the period January 1, 2020 to January 26, 2021. Here, we show that of the 4,420 registered SARS-CoV-2/COVID-19 studies, 935 (21.2%) address sex/gender solely in the context of recruitment, 237 (5.4%) plan sex-matched or representative samples or emphasized sex/gender reporting, and only 178 (4%) explicitly report a plan to include sex/gender as an analytical variable. Just eight (17.8%) of the 45 COVID-19 related clinical trials published in scientific journals until December 15, 2020 report sex-disaggregated results or subgroup analyses. Sex and gender have been associated with differences in SARS-CoV-2 incidence and clinical outcomes and therefore warrant consideration in study designs. Here, the authors assess registered and published clinical COVID-19 studies and find that sex-disaggregated analyses are infrequently presented or planned.</abstract>

<relatedItem type="constituent">
  <location>
    <url displayLabel="s41467-021-24265-8.pdf">https://pub.uni-bielefeld.de/download/2957048/2960331/s41467-021-24265-8.pdf</url>
  </location>
  <physicalDescription><internetMediaType>application/pdf</internetMediaType></physicalDescription>
  <accessCondition type="restrictionOnAccess">no</accessCondition>
</relatedItem>
<originInfo><publisher>Nature Publishing Group</publisher><dateIssued encoding="w3cdtf">2021</dateIssued>
</originInfo>
<language><languageTerm authority="iso639-2b" type="code">eng</languageTerm>
</language>



<relatedItem type="host"><titleInfo><title>Nature Communications</title></titleInfo>
  <identifier type="eIssn">2041-1723</identifier>
  <identifier type="MEDLINE">34230477</identifier>
  <identifier type="ISI">000672714100001</identifier><identifier type="urn">urn:nbn:de:0070-pub-29570485</identifier><identifier type="doi">10.1038/s41467-021-24265-8</identifier>
<part><detail type="volume"><number>12</number></detail><detail type="issue"><number>1</number></detail>
</part>
</relatedItem>


<extension>
<bibliographicCitation>
<ieee> E. Brady, et al., “Lack of consideration of sex and gender in COVID-19 clinical studies”, &lt;em&gt;Nature Communications&lt;/em&gt;,  vol. 12, 2021, : 4015.</ieee>
<apa>Brady, E., Nielsen, M. W., Andersen, J. P., &amp;amp; Oertelt-Prigione, S. (2021). Lack of consideration of sex and gender in COVID-19 clinical studies. &lt;em&gt;Nature Communications&lt;/em&gt;, &lt;em&gt;12&lt;/em&gt;(1), 4015. &lt;a href="https://doi.org/10.1038/s41467-021-24265-8" target="_blank"&gt;https://doi.org/10.1038/s41467-021-24265-8&lt;/a&gt;</apa>
<frontiers>Brady, E., Nielsen, M. W., Andersen, J. P., and Oertelt-Prigione, S. (2021). Lack of consideration of sex and gender in COVID-19 clinical studies. &lt;em&gt;Nature Communications&lt;/em&gt; 12:4015.</frontiers>
<dgps>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Brady, E., Nielsen, M.W., Andersen, J.P. &amp;amp; Oertelt-Prigione, S. (2021). Lack of consideration of sex and gender in COVID-19 clinical studies. &lt;em&gt;Nature Communications&lt;/em&gt;, &lt;em&gt;12&lt;/em&gt;(1): 4015. Nature Publishing Group. doi:10.1038/s41467-021-24265-8.&lt;/div&gt;</dgps>
<ama>Brady E, Nielsen MW, Andersen JP, Oertelt-Prigione S. Lack of consideration of sex and gender in COVID-19 clinical studies. &lt;em&gt;Nature Communications&lt;/em&gt;. 2021;12(1): 4015.</ama>
<angewandte-chemie>E.  Brady, M. W.  Nielsen, J. P.  Andersen, and S.  Oertelt-Prigione, “Lack of consideration of sex and gender in COVID-19 clinical studies”, &lt;em&gt;Nature Communications&lt;/em&gt;, &lt;strong&gt;2021&lt;/strong&gt;, &lt;em&gt;12&lt;/em&gt;, : 4015.</angewandte-chemie>
<apa_indent>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Brady, E., Nielsen, M. W., Andersen, J. P., &amp;amp; Oertelt-Prigione, S. (2021). Lack of consideration of sex and gender in COVID-19 clinical studies. &lt;em&gt;Nature Communications&lt;/em&gt;, &lt;em&gt;12&lt;/em&gt;(1), 4015. &lt;a href="https://doi.org/10.1038/s41467-021-24265-8" target="_blank"&gt;https://doi.org/10.1038/s41467-021-24265-8&lt;/a&gt;&lt;/div&gt;</apa_indent>
<harvard1>Brady, E., et al., 2021. Lack of consideration of sex and gender in COVID-19 clinical studies. &lt;em&gt;Nature Communications&lt;/em&gt;, 12(1): 4015.</harvard1>
<bio1>Brady E, Nielsen MW, Andersen JP, Oertelt-Prigione S (2021) &lt;br /&gt;Lack of consideration of sex and gender in COVID-19 clinical studies.&lt;br /&gt;Nature Communications 12(1): 4015.</bio1>
<wels>Brady, E.; Nielsen, M. W.; Andersen, J. P.; Oertelt-Prigione, S. (2021): Lack of consideration of sex and gender in COVID-19 clinical studies &lt;em&gt;Nature Communications&lt;/em&gt;,12:(1):4015</wels>
<default>Brady E, Nielsen MW, Andersen JP, Oertelt-Prigione S (2021) &lt;br /&gt;&lt;em&gt;Nature Communications&lt;/em&gt; 12(1): 4015.</default>
<mla>Brady, Emer, Nielsen, Mathias Wullum, Andersen, Jens Peter, and Oertelt-Prigione, Sabine. “Lack of consideration of sex and gender in COVID-19 clinical studies”. &lt;em&gt;Nature Communications&lt;/em&gt; 12.1 (2021): 4015.</mla>
<chicago>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Brady, Emer, Nielsen, Mathias Wullum, Andersen, Jens Peter, and Oertelt-Prigione, Sabine. 2021. “Lack of consideration of sex and gender in COVID-19 clinical studies”. &lt;em&gt;Nature Communications&lt;/em&gt; 12 (1): 4015.&lt;/div&gt;</chicago>
<lncs> Brady, E., Nielsen, M.W., Andersen, J.P., Oertelt-Prigione, S.: Lack of consideration of sex and gender in COVID-19 clinical studies. Nature Communications. 12, : 4015 (2021).</lncs>
</bibliographicCitation>
</extension>
<recordInfo><recordIdentifier>2957048</recordIdentifier><recordCreationDate encoding="w3cdtf">2021-08-30T12:06:08Z</recordCreationDate><recordChangeDate encoding="w3cdtf">2022-01-07T08:53:57Z</recordChangeDate>
</recordInfo>
</mods>